טוען...
A gene expression based predictor for myeloma patients at high risk of developing bone disease on bisphosphonate treatment
PURPOSE: Myeloma bone disease (BD) impairs quality of life and is associated with impaired survival. Even with effective bisphosphonate treatment a significant proportion of patients still develop skeletal-related events (SREs). Identifying such patients at presentation would allow treatment modific...
שמור ב:
| Main Authors: | , , , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2011
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3866998/ https://ncbi.nlm.nih.gov/pubmed/21856767 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-11-0994 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|